Annie Yoshiyama's most recent trade in Allogene Therapeutics Inc was a trade of 9,601 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on April 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Allogene Therapeutics Inc | Annie Yoshiyama | SVP, Finance | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 21 Apr 2025 | 9,601 | 130,663 (0%) | 0% | 1.4 | 13,537 | Common Stock |
| Allogene Therapeutics Inc | Annie Yoshiyama | SVP, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 128,093 | 128,093 | - | - | Stock Option (Right to buy) | |
| Allogene Therapeutics Inc | Annie Yoshiyama | SVP, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 36,232 | 137,990 (0%) | 0% | 0 | Common Stock |